Document Details
Form
Filing Date
Aug 25, 2023
Document Date
Aug 25, 2023
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.